Geneos Wealth Management’s Aflac AFL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$290K Sell
2,642
-8,379
-76% -$929K 0.01% 847
2025
Q4
$1.22M Sell
11,021
-28
-0.3% -$3.08K 0.03% 452
2025
Q3
$1.23M Sell
11,049
-900
-8% -$94.5K 0.03% 441
2025
Q2
$1.26M Sell
11,949
-12,579
-51% -$1.32M 0.03% 472
2025
Q1
$2.73M Buy
24,528
+12,831
+110% +$1.36M 0.04% 415
2024
Q4
$1.21M Sell
11,697
-279
-2% -$30.4K 0.04% 371
2024
Q3
$1.34M Buy
11,976
+723
+6% +$73.5K 0.05% 345
2024
Q2
$1.01M Hold
11,253
0.04% 361
2024
Q1
$966K Hold
11,253
0.04% 358
2023
Q4
$928K Sell
11,253
-780
-6% -$62.9K 0.05% 340
2023
Q3
$924K Buy
12,033
+46
+0.4% +$3.42K 0.05% 331
2023
Q2
$837K Buy
11,987
+493
+4% +$33K 0.04% 349
2023
Q1
$742K Sell
11,494
-898
-7% -$61.5K 0.05% 360
2022
Q4
$891K Sell
12,392
-773
-6% -$51.8K 0.05% 294
2022
Q3
$739K Sell
13,165
-2,137
-14% -$126K 0.05% 311
2022
Q2
$860K Buy
15,302
+60
+0.4% +$3.54K 0.04% 360
2022
Q1
$981K Sell
15,242
-3,077
-17% -$193K 0.04% 360
2021
Q4
$1.07M Buy
18,319
+290
+2% +$16.3K 0.04% 378
2021
Q3
$954K Sell
18,029
-67
-0.4% -$3.66K 0.04% 395
2021
Q2
$979K Sell
18,096
-4,081
-18% -$223K 0.04% 370
2021
Q1
$1.19M Sell
22,177
-2,310
-9% -$111K 0.03% 380
2020
Q4
$1.07M Buy
24,487
+18,207
+290% +$745K 0.04% 332
2020
Q3
$224K Buy
6,280
+44
+0.7% +$1.6K 0.01% 652
2020
Q2
$216K Sell
6,236
-1,300
-17% -$47K 0.01% 645
2020
Q1
$266K Buy
7,536
+800
+12% +$36.6K 0.02% 527
2019
Q4
$354K Hold
6,736
0.02% 523
2019
Q3
$349K Buy
6,736
+1,200
+22% +$63.4K 0.02% 493
2019
Q2
$303K Buy
5,536
+110
+2% +$5.67K 0.02% 540
2019
Q1
$271K Hold
5,426
0.02% 561
2018
Q4
$243K Hold
5,426
0.02% 545
2018
Q3
$255K Sell
5,426
-3,000
-36% -$137K 0.02% 561
2018
Q2
$362K Sell
8,426
-3,934
-32% -$177K 0.03% 391
2018
Q1
$540K Sell
12,360
-1,074
-8% -$47.5K 0.05% 296
2017
Q4
$589K Buy
13,434
+1,374
+11% +$58.6K 0.05% 284
2017
Q3
$490K Sell
12,060
-1,200
-9% -$48.3K 0.05% 304
2017
Q2
$515K Sell
13,260
-1,568
-11% -$58.9K 0.05% 283
2017
Q1
$536K Sell
14,828
-448
-3% -$15.9K 0.06% 260
2016
Q4
$531K Sell
15,276
-1,064
-7% -$37.5K 0.07% 237
2016
Q3
$587K Buy
16,340
+244
+2% +$8.88K 0.08% 222
2016
Q2
$583K Sell
16,096
-180
-1% -$6.15K 0.08% 220
2016
Q1
$521K Buy
+16,276
New +$483K 0.08% 229

Other funds holding AFL

Geneos Wealth Management's AFL Position: Q1 2026 in Review

Geneos Wealth Management reduced its Aflac (AFL) stake by 76% in Q1 2026, selling an estimated $929K and leaving 2,642 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #847.

Geneos Wealth Management first reported a position in AFL in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.73M in Q1 2025. 1,652 funds tracked by Wall St. Rank hold AFL as of Q1 2026.

  • Geneos Wealth Management held 2,642 shares of Aflac worth $290K as of Q1 2026.
  • Geneos Wealth Management sold 8,379 Aflac shares in Q1 2026, an estimated $929K.
  • Aflac made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #847 holding.
  • Geneos Wealth Management first reported a position in Aflac in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Aflac position peaked at $2.73M in Q1 2025.
  • 1,652 funds tracked by Wall St. Rank held Aflac as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.